nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadofosveset trisodium—ALB—Estropipate—osteoporosis	0.374	0.707	CbGbCtD
Gadofosveset trisodium—ALB—Estradiol—osteoporosis	0.155	0.293	CbGbCtD
Gadofosveset trisodium—ALB—Platelet degranulation—WDR1—osteoporosis	0.00033	0.0441	CbGpPWpGaD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	0.000314	0.042	CbGpPWpGaD
Gadofosveset trisodium—ALB—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.000314	0.0419	CbGpPWpGaD
Gadofosveset trisodium—ALB—Lipoprotein metabolism—P4HB—osteoporosis	0.000309	0.0412	CbGpPWpGaD
Gadofosveset trisodium—ALB—Lipid and lipoprotein metabolism—MGLL—osteoporosis	0.000302	0.0403	CbGpPWpGaD
Gadofosveset trisodium—Rash—Etidronic acid—osteoporosis	0.000272	0.000586	CcSEcCtD
Gadofosveset trisodium—Convulsion—Zoledronate—osteoporosis	0.000272	0.000586	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Etidronic acid—osteoporosis	0.000272	0.000586	CcSEcCtD
Gadofosveset trisodium—Vertigo—Conjugated Estrogens—osteoporosis	0.000271	0.000585	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Pamidronate—osteoporosis	0.000271	0.000584	CcSEcCtD
Gadofosveset trisodium—Syncope—Conjugated Estrogens—osteoporosis	0.000271	0.000584	CcSEcCtD
Gadofosveset trisodium—Hypertension—Zoledronate—osteoporosis	0.000271	0.000584	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Alendronate—osteoporosis	0.000271	0.000584	CcSEcCtD
Gadofosveset trisodium—Headache—Etidronic acid—osteoporosis	0.00027	0.000582	CcSEcCtD
Gadofosveset trisodium—Asthenia—Estropipate—osteoporosis	0.000268	0.000577	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Estradiol—osteoporosis	0.000268	0.000577	CcSEcCtD
Gadofosveset trisodium—Anorexia—Pamidronate—osteoporosis	0.000267	0.000576	CcSEcCtD
Gadofosveset trisodium—Chest pain—Zoledronate—osteoporosis	0.000267	0.000576	CcSEcCtD
Gadofosveset trisodium—Palpitations—Conjugated Estrogens—osteoporosis	0.000267	0.000575	CcSEcCtD
Gadofosveset trisodium—Anxiety—Zoledronate—osteoporosis	0.000266	0.000574	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000265	0.000572	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000265	0.000572	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Risedronate—osteoporosis	0.000265	0.000571	CcSEcCtD
Gadofosveset trisodium—Pruritus—Estropipate—osteoporosis	0.000264	0.000569	CcSEcCtD
Gadofosveset trisodium—Asthenia—Alendronate—osteoporosis	0.000264	0.000568	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Ibandronate—osteoporosis	0.000264	0.000568	CcSEcCtD
Gadofosveset trisodium—Cough—Conjugated Estrogens—osteoporosis	0.000264	0.000568	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Risedronate—osteoporosis	0.000263	0.000567	CcSEcCtD
Gadofosveset trisodium—Hypotension—Pamidronate—osteoporosis	0.000262	0.000565	CcSEcCtD
Gadofosveset trisodium—Convulsion—Conjugated Estrogens—osteoporosis	0.000262	0.000564	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Zoledronate—osteoporosis	0.000261	0.000563	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000261	0.000563	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet degranulation—CAP1—osteoporosis	0.000261	0.0348	CbGpPWpGaD
Gadofosveset trisodium—Fatigue—Ethinyl Estradiol—osteoporosis	0.000261	0.000562	CcSEcCtD
Gadofosveset trisodium—Pruritus—Alendronate—osteoporosis	0.00026	0.00056	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Risedronate—osteoporosis	0.00026	0.00056	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Estradiol—osteoporosis	0.00026	0.000559	CcSEcCtD
Gadofosveset trisodium—Constipation—Ethinyl Estradiol—osteoporosis	0.000259	0.000557	CcSEcCtD
Gadofosveset trisodium—Confusional state—Zoledronate—osteoporosis	0.000258	0.000557	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Calcitriol—osteoporosis	0.000258	0.000556	CcSEcCtD
Gadofosveset trisodium—Flushing—Estradiol—osteoporosis	0.000258	0.000556	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Estradiol—osteoporosis	0.000258	0.000556	CcSEcCtD
Gadofosveset trisodium—Chest pain—Conjugated Estrogens—osteoporosis	0.000257	0.000554	CcSEcCtD
Gadofosveset trisodium—Asthenia—Ibandronate—osteoporosis	0.000257	0.000553	CcSEcCtD
Gadofosveset trisodium—Anxiety—Conjugated Estrogens—osteoporosis	0.000256	0.000552	CcSEcCtD
Gadofosveset trisodium—Nausea—Etidronic acid—osteoporosis	0.000256	0.000552	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Zoledronate—osteoporosis	0.000256	0.000552	CcSEcCtD
Gadofosveset trisodium—Oedema—Zoledronate—osteoporosis	0.000256	0.000552	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000255	0.000551	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Estropipate—osteoporosis	0.000255	0.00055	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Risedronate—osteoporosis	0.000255	0.000549	CcSEcCtD
Gadofosveset trisodium—Infection—Zoledronate—osteoporosis	0.000254	0.000548	CcSEcCtD
Gadofosveset trisodium—Fatigue—Risedronate—osteoporosis	0.000254	0.000548	CcSEcCtD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000253	0.0338	CbGpPWpGaD
Gadofosveset trisodium—Pruritus—Ibandronate—osteoporosis	0.000253	0.000546	CcSEcCtD
Gadofosveset trisodium—Pain—Risedronate—osteoporosis	0.000252	0.000544	CcSEcCtD
Gadofosveset trisodium—Constipation—Risedronate—osteoporosis	0.000252	0.000544	CcSEcCtD
Gadofosveset trisodium—Shock—Zoledronate—osteoporosis	0.000252	0.000543	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Pamidronate—osteoporosis	0.000252	0.000543	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Alendronate—osteoporosis	0.000251	0.000542	CcSEcCtD
Gadofosveset trisodium—Asthenia—Calcitriol—osteoporosis	0.000251	0.000542	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Zoledronate—osteoporosis	0.000251	0.000541	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Estradiol—osteoporosis	0.000251	0.000541	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Estradiol—osteoporosis	0.00025	0.00054	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Pamidronate—osteoporosis	0.00025	0.000539	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Zoledronate—osteoporosis	0.00025	0.000539	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000249	0.000537	CcSEcCtD
Gadofosveset trisodium—Chills—Estradiol—osteoporosis	0.000249	0.000537	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Zoledronate—osteoporosis	0.000249	0.000536	CcSEcCtD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	0.000249	0.0332	CbGpPWpGaD
Gadofosveset trisodium—Pruritus—Calcitriol—osteoporosis	0.000248	0.000534	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Zoledronate—osteoporosis	0.000248	0.000534	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000247	0.000533	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Raloxifene—osteoporosis	0.000247	0.000533	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Pamidronate—osteoporosis	0.000247	0.000532	CcSEcCtD
Gadofosveset trisodium—Dizziness—Estropipate—osteoporosis	0.000247	0.000532	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000247	0.000531	CcSEcCtD
Gadofosveset trisodium—Oedema—Conjugated Estrogens—osteoporosis	0.000247	0.000531	CcSEcCtD
Gadofosveset trisodium—Infection—Conjugated Estrogens—osteoporosis	0.000245	0.000528	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Ibandronate—osteoporosis	0.000245	0.000528	CcSEcCtD
Gadofosveset trisodium—Anorexia—Zoledronate—osteoporosis	0.000244	0.000526	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Pamidronate—osteoporosis	0.000244	0.000525	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Estradiol—osteoporosis	0.000243	0.000525	CcSEcCtD
Gadofosveset trisodium—Dizziness—Alendronate—osteoporosis	0.000243	0.000524	CcSEcCtD
Gadofosveset trisodium—Shock—Conjugated Estrogens—osteoporosis	0.000243	0.000523	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000242	0.000522	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000242	0.000521	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Estradiol—osteoporosis	0.000242	0.000521	CcSEcCtD
Gadofosveset trisodium—Erythema—Estradiol—osteoporosis	0.000242	0.000521	CcSEcCtD
Gadofosveset trisodium—Fatigue—Pamidronate—osteoporosis	0.000242	0.000521	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Risedronate—osteoporosis	0.000241	0.00052	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Conjugated Estrogens—osteoporosis	0.000241	0.000519	CcSEcCtD
Gadofosveset trisodium—Urticaria—Ethinyl Estradiol—osteoporosis	0.00024	0.000518	CcSEcCtD
Gadofosveset trisodium—Pain—Pamidronate—osteoporosis	0.00024	0.000517	CcSEcCtD
Gadofosveset trisodium—Constipation—Pamidronate—osteoporosis	0.00024	0.000517	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Calcitriol—osteoporosis	0.00024	0.000517	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Conjugated Estrogens—osteoporosis	0.000239	0.000516	CcSEcCtD
Gadofosveset trisodium—Hypotension—Zoledronate—osteoporosis	0.000239	0.000516	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000239	0.000515	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000239	0.000515	CcSEcCtD
Gadofosveset trisodium—Dizziness—Raloxifene—osteoporosis	0.000239	0.000515	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000238	0.000514	CcSEcCtD
Gadofosveset trisodium—Flatulence—Estradiol—osteoporosis	0.000238	0.000514	CcSEcCtD
Gadofosveset trisodium—Vomiting—Estropipate—osteoporosis	0.000237	0.000511	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Estradiol—osteoporosis	0.000237	0.00051	CcSEcCtD
Gadofosveset trisodium—Dizziness—Ibandronate—osteoporosis	0.000237	0.00051	CcSEcCtD
Gadofosveset trisodium—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A2—osteoporosis	0.000236	0.0315	CbGpPWpGaD
Gadofosveset trisodium—Rash—Estropipate—osteoporosis	0.000235	0.000507	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Estropipate—osteoporosis	0.000235	0.000507	CcSEcCtD
Gadofosveset trisodium—Anorexia—Conjugated Estrogens—osteoporosis	0.000235	0.000507	CcSEcCtD
Gadofosveset trisodium—Urticaria—Risedronate—osteoporosis	0.000234	0.000505	CcSEcCtD
Gadofosveset trisodium—Headache—Estropipate—osteoporosis	0.000234	0.000504	CcSEcCtD
Gadofosveset trisodium—Vomiting—Alendronate—osteoporosis	0.000234	0.000504	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Risedronate—osteoporosis	0.000233	0.000502	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Risedronate—osteoporosis	0.000233	0.000502	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Estradiol—osteoporosis	0.000232	0.000501	CcSEcCtD
Gadofosveset trisodium—Rash—Alendronate—osteoporosis	0.000232	0.000499	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Alendronate—osteoporosis	0.000231	0.000499	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Pamidronate—osteoporosis	0.000231	0.000498	CcSEcCtD
Gadofosveset trisodium—Hypotension—Conjugated Estrogens—osteoporosis	0.00023	0.000497	CcSEcCtD
Gadofosveset trisodium—Headache—Alendronate—osteoporosis	0.00023	0.000496	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Zoledronate—osteoporosis	0.00023	0.000496	CcSEcCtD
Gadofosveset trisodium—Vomiting—Raloxifene—osteoporosis	0.00023	0.000495	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Pamidronate—osteoporosis	0.000229	0.000494	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Zoledronate—osteoporosis	0.000228	0.000492	CcSEcCtD
Gadofosveset trisodium—Rash—Raloxifene—osteoporosis	0.000228	0.000491	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Raloxifene—osteoporosis	0.000228	0.000491	CcSEcCtD
Gadofosveset trisodium—Vomiting—Ibandronate—osteoporosis	0.000227	0.00049	CcSEcCtD
Gadofosveset trisodium—Tremor—Estradiol—osteoporosis	0.000227	0.000488	CcSEcCtD
Gadofosveset trisodium—Headache—Raloxifene—osteoporosis	0.000226	0.000488	CcSEcCtD
Gadofosveset trisodium—Rash—Ibandronate—osteoporosis	0.000226	0.000486	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Ibandronate—osteoporosis	0.000225	0.000486	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Zoledronate—osteoporosis	0.000225	0.000486	CcSEcCtD
Gadofosveset trisodium—Headache—Ibandronate—osteoporosis	0.000224	0.000483	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000223	0.00048	CcSEcCtD
Gadofosveset trisodium—Vomiting—Calcitriol—osteoporosis	0.000223	0.00048	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Zoledronate—osteoporosis	0.000223	0.00048	CcSEcCtD
Gadofosveset trisodium—Nausea—Estropipate—osteoporosis	0.000222	0.000478	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Pamidronate—osteoporosis	0.000222	0.000478	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Pamidronate—osteoporosis	0.000222	0.000478	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000221	0.000477	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000221	0.000476	CcSEcCtD
Gadofosveset trisodium—Rash—Calcitriol—osteoporosis	0.000221	0.000476	CcSEcCtD
Gadofosveset trisodium—Fatigue—Zoledronate—osteoporosis	0.000221	0.000476	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Calcitriol—osteoporosis	0.000221	0.000476	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00022	0.000474	CcSEcCtD
Gadofosveset trisodium—Headache—Calcitriol—osteoporosis	0.000219	0.000473	CcSEcCtD
Gadofosveset trisodium—Constipation—Zoledronate—osteoporosis	0.000219	0.000472	CcSEcCtD
Gadofosveset trisodium—Pain—Zoledronate—osteoporosis	0.000219	0.000472	CcSEcCtD
Gadofosveset trisodium—Nausea—Alendronate—osteoporosis	0.000218	0.000471	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Risedronate—osteoporosis	0.000217	0.000468	CcSEcCtD
Gadofosveset trisodium—Vertigo—Estradiol—osteoporosis	0.000217	0.000468	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000217	0.000468	CcSEcCtD
Gadofosveset trisodium—Asthenia—Ethinyl Estradiol—osteoporosis	0.000217	0.000468	CcSEcCtD
Gadofosveset trisodium—Syncope—Estradiol—osteoporosis	0.000217	0.000467	CcSEcCtD
Gadofosveset trisodium—Nausea—Raloxifene—osteoporosis	0.000215	0.000463	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000214	0.000462	CcSEcCtD
Gadofosveset trisodium—Pruritus—Ethinyl Estradiol—osteoporosis	0.000214	0.000461	CcSEcCtD
Gadofosveset trisodium—Palpitations—Estradiol—osteoporosis	0.000214	0.000461	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000213	0.000459	CcSEcCtD
Gadofosveset trisodium—Fatigue—Conjugated Estrogens—osteoporosis	0.000213	0.000458	CcSEcCtD
Gadofosveset trisodium—Nausea—Ibandronate—osteoporosis	0.000213	0.000458	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Estradiol—osteoporosis	0.000212	0.000458	CcSEcCtD
Gadofosveset trisodium—Asthenia—Risedronate—osteoporosis	0.000212	0.000456	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Zoledronate—osteoporosis	0.000211	0.000455	CcSEcCtD
Gadofosveset trisodium—Cough—Estradiol—osteoporosis	0.000211	0.000455	CcSEcCtD
Gadofosveset trisodium—Pain—Conjugated Estrogens—osteoporosis	0.000211	0.000454	CcSEcCtD
Gadofosveset trisodium—Constipation—Conjugated Estrogens—osteoporosis	0.000211	0.000454	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Zoledronate—osteoporosis	0.000209	0.000451	CcSEcCtD
Gadofosveset trisodium—Hypertension—Estradiol—osteoporosis	0.000209	0.00045	CcSEcCtD
Gadofosveset trisodium—Pruritus—Risedronate—osteoporosis	0.000209	0.00045	CcSEcCtD
Gadofosveset trisodium—Nausea—Calcitriol—osteoporosis	0.000208	0.000448	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000207	0.000446	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Pamidronate—osteoporosis	0.000207	0.000445	CcSEcCtD
Gadofosveset trisodium—Chest pain—Estradiol—osteoporosis	0.000206	0.000444	CcSEcCtD
Gadofosveset trisodium—ALB—Lipid and lipoprotein metabolism—P4HB—osteoporosis	0.000205	0.0274	CbGpPWpGaD
Gadofosveset trisodium—Anxiety—Estradiol—osteoporosis	0.000205	0.000442	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000204	0.000441	CcSEcCtD
Gadofosveset trisodium—Urticaria—Zoledronate—osteoporosis	0.000203	0.000438	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Zoledronate—osteoporosis	0.000202	0.000436	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Zoledronate—osteoporosis	0.000202	0.000436	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Risedronate—osteoporosis	0.000202	0.000435	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000202	0.000435	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Estradiol—osteoporosis	0.000201	0.000434	CcSEcCtD
Gadofosveset trisodium—Asthenia—Pamidronate—osteoporosis	0.000201	0.000434	CcSEcCtD
Gadofosveset trisodium—Dizziness—Ethinyl Estradiol—osteoporosis	0.0002	0.000431	CcSEcCtD
Gadofosveset trisodium—Confusional state—Estradiol—osteoporosis	0.000199	0.000429	CcSEcCtD
Gadofosveset trisodium—Pruritus—Pamidronate—osteoporosis	0.000198	0.000427	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Estradiol—osteoporosis	0.000197	0.000425	CcSEcCtD
Gadofosveset trisodium—Oedema—Estradiol—osteoporosis	0.000197	0.000425	CcSEcCtD
Gadofosveset trisodium—Infection—Estradiol—osteoporosis	0.000196	0.000423	CcSEcCtD
Gadofosveset trisodium—Urticaria—Conjugated Estrogens—osteoporosis	0.000196	0.000422	CcSEcCtD
Gadofosveset trisodium—Dizziness—Risedronate—osteoporosis	0.000195	0.00042	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000195	0.00042	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000195	0.00042	CcSEcCtD
Gadofosveset trisodium—Shock—Estradiol—osteoporosis	0.000194	0.000418	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Estradiol—osteoporosis	0.000193	0.000417	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Estradiol—osteoporosis	0.000193	0.000415	CcSEcCtD
Gadofosveset trisodium—Vomiting—Ethinyl Estradiol—osteoporosis	0.000192	0.000415	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Pamidronate—osteoporosis	0.000192	0.000413	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Estradiol—osteoporosis	0.000192	0.000413	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Estradiol—osteoporosis	0.000191	0.000411	CcSEcCtD
Gadofosveset trisodium—Rash—Ethinyl Estradiol—osteoporosis	0.000191	0.000411	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000191	0.000411	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet degranulation—PLEK—osteoporosis	0.00019	0.0253	CbGpPWpGaD
Gadofosveset trisodium—Headache—Ethinyl Estradiol—osteoporosis	0.000189	0.000408	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Zoledronate—osteoporosis	0.000189	0.000407	CcSEcCtD
Gadofosveset trisodium—Vomiting—Risedronate—osteoporosis	0.000187	0.000404	CcSEcCtD
Gadofosveset trisodium—Rash—Risedronate—osteoporosis	0.000186	0.000401	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Risedronate—osteoporosis	0.000186	0.0004	CcSEcCtD
Gadofosveset trisodium—Dizziness—Pamidronate—osteoporosis	0.000185	0.0004	CcSEcCtD
Gadofosveset trisodium—Headache—Risedronate—osteoporosis	0.000185	0.000398	CcSEcCtD
Gadofosveset trisodium—Asthenia—Zoledronate—osteoporosis	0.000184	0.000396	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000182	0.000392	CcSEcCtD
Gadofosveset trisodium—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—osteoporosis	0.000181	0.0242	CbGpPWpGaD
Gadofosveset trisodium—Pruritus—Zoledronate—osteoporosis	0.000181	0.00039	CcSEcCtD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.000181	0.0241	CbGpPWpGaD
Gadofosveset trisodium—Nausea—Ethinyl Estradiol—osteoporosis	0.00018	0.000387	CcSEcCtD
Gadofosveset trisodium—Vomiting—Pamidronate—osteoporosis	0.000178	0.000384	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Estradiol—osteoporosis	0.000177	0.000382	CcSEcCtD
Gadofosveset trisodium—Asthenia—Conjugated Estrogens—osteoporosis	0.000177	0.000381	CcSEcCtD
Gadofosveset trisodium—Rash—Pamidronate—osteoporosis	0.000177	0.000381	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Pamidronate—osteoporosis	0.000177	0.000381	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Estradiol—osteoporosis	0.000176	0.000379	CcSEcCtD
Gadofosveset trisodium—Headache—Pamidronate—osteoporosis	0.000176	0.000379	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Zoledronate—osteoporosis	0.000175	0.000378	CcSEcCtD
Gadofosveset trisodium—Nausea—Risedronate—osteoporosis	0.000175	0.000378	CcSEcCtD
Gadofosveset trisodium—Pruritus—Conjugated Estrogens—osteoporosis	0.000174	0.000376	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Estradiol—osteoporosis	0.000174	0.000374	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Estradiol—osteoporosis	0.000172	0.00037	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Estradiol—osteoporosis	0.00017	0.000367	CcSEcCtD
Gadofosveset trisodium—Fatigue—Estradiol—osteoporosis	0.00017	0.000367	CcSEcCtD
Gadofosveset trisodium—Dizziness—Zoledronate—osteoporosis	0.000169	0.000365	CcSEcCtD
Gadofosveset trisodium—Pain—Estradiol—osteoporosis	0.000169	0.000364	CcSEcCtD
Gadofosveset trisodium—Constipation—Estradiol—osteoporosis	0.000169	0.000364	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000169	0.000364	CcSEcCtD
Gadofosveset trisodium—Nausea—Pamidronate—osteoporosis	0.000166	0.000359	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet degranulation—TLN1—osteoporosis	0.000163	0.0218	CbGpPWpGaD
Gadofosveset trisodium—Dizziness—Conjugated Estrogens—osteoporosis	0.000163	0.000351	CcSEcCtD
Gadofosveset trisodium—Vomiting—Zoledronate—osteoporosis	0.000163	0.000351	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Estradiol—osteoporosis	0.000163	0.000351	CcSEcCtD
Gadofosveset trisodium—Rash—Zoledronate—osteoporosis	0.000161	0.000348	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Estradiol—osteoporosis	0.000161	0.000348	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Zoledronate—osteoporosis	0.000161	0.000348	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet degranulation—VCL—osteoporosis	0.000161	0.0215	CbGpPWpGaD
Gadofosveset trisodium—Headache—Zoledronate—osteoporosis	0.00016	0.000346	CcSEcCtD
Gadofosveset trisodium—Vomiting—Conjugated Estrogens—osteoporosis	0.000157	0.000338	CcSEcCtD
Gadofosveset trisodium—Urticaria—Estradiol—osteoporosis	0.000157	0.000338	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Estradiol—osteoporosis	0.000156	0.000336	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Estradiol—osteoporosis	0.000156	0.000336	CcSEcCtD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.000156	0.0208	CbGpPWpGaD
Gadofosveset trisodium—Rash—Conjugated Estrogens—osteoporosis	0.000155	0.000335	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Conjugated Estrogens—osteoporosis	0.000155	0.000335	CcSEcCtD
Gadofosveset trisodium—Headache—Conjugated Estrogens—osteoporosis	0.000154	0.000333	CcSEcCtD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.000154	0.0205	CbGpPWpGaD
Gadofosveset trisodium—Nausea—Zoledronate—osteoporosis	0.000152	0.000328	CcSEcCtD
Gadofosveset trisodium—Nausea—Conjugated Estrogens—osteoporosis	0.000146	0.000316	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000146	0.0195	CbGpPWpGaD
Gadofosveset trisodium—Hypersensitivity—Estradiol—osteoporosis	0.000145	0.000313	CcSEcCtD
Gadofosveset trisodium—Asthenia—Estradiol—osteoporosis	0.000142	0.000305	CcSEcCtD
Gadofosveset trisodium—Pruritus—Estradiol—osteoporosis	0.00014	0.000301	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Estradiol—osteoporosis	0.000135	0.000291	CcSEcCtD
Gadofosveset trisodium—Dizziness—Estradiol—osteoporosis	0.00013	0.000281	CcSEcCtD
Gadofosveset trisodium—Vomiting—Estradiol—osteoporosis	0.000125	0.00027	CcSEcCtD
Gadofosveset trisodium—Rash—Estradiol—osteoporosis	0.000124	0.000268	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Estradiol—osteoporosis	0.000124	0.000268	CcSEcCtD
Gadofosveset trisodium—Headache—Estradiol—osteoporosis	0.000124	0.000266	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet degranulation—FGA—osteoporosis	0.000122	0.0163	CbGpPWpGaD
Gadofosveset trisodium—Nausea—Estradiol—osteoporosis	0.000117	0.000253	CcSEcCtD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000116	0.0155	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000116	0.0155	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet degranulation—FGB—osteoporosis	0.000111	0.0148	CbGpPWpGaD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—SOD2—osteoporosis	0.000107	0.0142	CbGpPWpGaD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.000106	0.0141	CbGpPWpGaD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—MTHFR—osteoporosis	9.38e-05	0.0125	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	9.19e-05	0.0123	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—SOD2—osteoporosis	8.67e-05	0.0116	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	8.41e-05	0.0112	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—GPX1—osteoporosis	8.27e-05	0.011	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—MTHFR—osteoporosis	7.63e-05	0.0102	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—WDR1—osteoporosis	7.55e-05	0.0101	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	7.25e-05	0.00968	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	7.15e-05	0.00955	CbGpPWpGaD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	6.88e-05	0.00919	CbGpPWpGaD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	6.57e-05	0.00877	CbGpPWpGaD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	6.06e-05	0.00809	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	6.01e-05	0.00802	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	5.98e-05	0.00798	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—CAP1—osteoporosis	5.97e-05	0.00796	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	5.69e-05	0.0076	CbGpPWpGaD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	5.57e-05	0.00743	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	5.42e-05	0.00723	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet degranulation—IGF1—osteoporosis	5.03e-05	0.00672	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	4.93e-05	0.00658	CbGpPWpGaD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	4.79e-05	0.0064	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—MGLL—osteoporosis	4.74e-05	0.00633	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—IL1B—osteoporosis	4.53e-05	0.00605	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.43e-05	0.00591	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PLEK—osteoporosis	4.33e-05	0.00579	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—ANXA2—osteoporosis	4.33e-05	0.00579	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.31e-05	0.00576	CbGpPWpGaD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	4.04e-05	0.00539	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.75e-05	0.00501	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—TLN1—osteoporosis	3.74e-05	0.00499	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—VCL—osteoporosis	3.69e-05	0.00492	CbGpPWpGaD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	3.6e-05	0.0048	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.45e-05	0.0046	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—TNF—osteoporosis	3.29e-05	0.00439	CbGpPWpGaD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	3.26e-05	0.00435	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—RAP1A—osteoporosis	3.08e-05	0.00411	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet degranulation—TGFB1—osteoporosis	3.02e-05	0.00403	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.93e-05	0.00392	CbGpPWpGaD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	2.87e-05	0.00384	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—FGA—osteoporosis	2.79e-05	0.00373	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PKM—osteoporosis	2.67e-05	0.00357	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—FDPS—osteoporosis	2.67e-05	0.00357	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—IL6—osteoporosis	2.65e-05	0.00354	CbGpPWpGaD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—TNF—osteoporosis	2.61e-05	0.00348	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—FGB—osteoporosis	2.54e-05	0.00339	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PGLS—osteoporosis	2.54e-05	0.00338	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GPD2—osteoporosis	2.54e-05	0.00338	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PNP—osteoporosis	2.32e-05	0.0031	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ATIC—osteoporosis	2.32e-05	0.0031	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	2.23e-05	0.00298	CbGpPWpGaD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—IL6—osteoporosis	2.11e-05	0.00281	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—OXCT1—osteoporosis	1.97e-05	0.00263	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CA2—osteoporosis	1.97e-05	0.00263	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—MGLL—osteoporosis	1.92e-05	0.00257	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.81e-05	0.00242	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—IDH2—osteoporosis	1.63e-05	0.00218	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CYP27A1—osteoporosis	1.54e-05	0.00205	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ACP5—osteoporosis	1.49e-05	0.002	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.48e-05	0.00197	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.41e-05	0.00188	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—TPI1—osteoporosis	1.39e-05	0.00185	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.34e-05	0.00179	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—P4HB—osteoporosis	1.31e-05	0.00174	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GAPDH—osteoporosis	1.28e-05	0.00171	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—RAP1A—osteoporosis	1.25e-05	0.00167	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—IGF1—osteoporosis	1.15e-05	0.00154	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.09e-05	0.00145	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ENO1—osteoporosis	1.01e-05	0.00135	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PSMA5—osteoporosis	9.95e-06	0.00133	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PSMA2—osteoporosis	9.95e-06	0.00133	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CYP19A1—osteoporosis	8.07e-06	0.00108	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—TGFB1—osteoporosis	6.9e-06	0.000921	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ADCY5—osteoporosis	6.59e-06	0.00088	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GPX1—osteoporosis	6.57e-06	0.000877	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—MTHFR—osteoporosis	6.06e-06	0.00081	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—POMC—osteoporosis	4.85e-06	0.000647	CbGpPWpGaD
